Transactions of the Royal Society of Tropical Medicine and Hygiene 1985-01-01

The effect of allopurinol ribonucleoside and formycin B on Trypanosoma cruzi infections in mice.

S L Croft, R A Neal

Index: Trans. R. Soc. Trop. Med. Hyg. 79(4) , 517-8, (1985)

Full Text: HTML

Abstract

The anti-Trypanosoma cruzi effect of allopurinol ribonucleoside and formycin B was examined against infections of the sensitive Y and Peru strains in inbred mice, strain DBA/1. Allopurinol ribonucleoside given in the drinking water at doses calculated to be 239, 511 and 929 mg/kg/day for 28 days, prevented the death of the mice but did not eradicate the infection. Formycin B given orally at 100 and 10 mg/kg/day X 5 days, showed a similar effect.


Related Compounds

Related Articles:

Activity of inosine analogs against Pneumocystis carinii in culture.

1986-07-01

[Antimicrob. Agents Chemother. 30(1) , 181-3, (1986)]

A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.

1988-03-01

[Am. J. Trop. Med. Hyg. 38(2) , 304-7, (1988)]

On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.

1983-07-15

[Biochem. Pharmacol. 32(14) , 2167-74, (1983)]

Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.

1984-10-01

[J. Infect. Dis. 150(4) , 602-8, (1984)]

Pharmacokinetics and metabolism of allopurinol riboside.

1991-05-01

[Clin. Pharmacol. Ther. 49(5) , 506-14, (1991)]

More Articles...